文献速递妇女保健预防保健、筛查与疫苗

无窥器医生取样用于人乳头瘤病毒检测:老年女性横断面研究

Non-speculum clinician-taken samples for human papillomavirus testing: a cross-sectional study in older women.
PubMed 文献 · Br J Gen Pract · 2022-07-28

该横断面研究在伦敦11家全科诊所和4家阴道镜诊所纳入≥50岁阴道镜受检者、≥35岁确诊CIN2+者及50-64岁常规筛查女性,评估无窥器医生采集阴道样本HPV检测的性能与可接受性。作者认为该法可行,需更大研究进一步探索,总体性能与自取样大致相当。

要点

  • 无窥器医生取样HPV检测对CIN2+敏感性83.3%(95%CI 60.8-94.2,n=15/18)。
  • 细胞学阴性女性中HPV特异性96.4%(95%CI 92.7-98.5), concordance 96.6%(κ 72.4%)。

核心结论

  • 无窥器医生采集阴道样本HPV检测是可行方法,需更大研究进一步探索。
  • 总体检测性能与自取样大致相当。

研究设计与样本

  • 横断面研究,2017年8月至2019年1月在伦敦11家全科诊所和4家阴道镜诊所开展。
  • 纳入≥50岁因窥器HPV阳性筛查结果转诊阴道镜的女性、≥35岁确诊CIN2+的女性及50-64岁常规筛查女性。
  • 采集无窥器和常规窥器样本,在确诊CIN2+者中评估敏感性,在细胞学阴性者中评估HPV特异性及一致性。

主要发现

  • 无窥器取样检测CIN2+的敏感性为83.3%(95%CI 60.8-94.2,n=15/18)。
  • CIN2+阳性女性中,无窥器取样前≤91天内有窥器取样者结果完全一致(n=12)。
  • 204例细胞学阴性女性中,HPV特异性为96.4%(95%CI 92.7-98.5),96.6%结果一致(κ 72.4%)。

关键数值与推荐

  • 无窥器取样对CIN2+敏感性83.3%(95%CI 60.8-94.2,n=15/18)。
  • 细胞学阴性女性中HPV特异性96.4%(95%CI 92.7-98.5),一致性96.6%(κ 72.4%)。

临床怎么用

  • 对于绝经后或窥器检查不适的女性,可考虑无窥器医生采集阴道样本行HPV检测。
  • 该取样方式可作为宫颈筛查的备选途径,但需在更大研究中验证。

局限性

  • 作者指出需更大规模研究进一步探索。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cervical cancer incidence and mortality are high in women aged ≥65 years, despite the disease being preventable by screening. Speculum-based screening can become more uncomfortable after the menopause. AIM: To examine test performance and acceptability of human papillomavirus (HPV) testing on clinician-collected vaginal samples without a speculum (non-speculum). DESIGN AND SETTING: Cross-sectional study in 11 GP practices and four colposcopy clinics in London, UK, between August 2017 and January 2019. METHOD: Non-speculum and conventional (speculum) samples were collected from women aged ≥50 years attending for a colposcopy (following a speculum HPV-positive screening result) or women aged ≥35 years (with confirmed cervical intraepithelial neoplasia (CIN) 2+), and women aged 50-64 years attending routine screening. Sensitivity to CIN2+ was assessed among women with confirmed CIN2+ (colposcopy). Specificity to HPV relative to speculum sampling and overall concordance was assessed among women with negative cytology (routine screening). RESULTS: The sensitivity of non-speculum sampling for detecting CIN2+ was 83.3% (95% confidence interval [CI] = 60.8 to 94.2) (n = 15/18). There was complete concordance among women with positive CIN2+ who had a speculum sample ≤91 days prior to the non-speculum sample (n = 12). Among 204 women with negative cytology, the specificity to HPV was 96.4% (95% CI = 92.7 to 98.5), with 96.6% concordant results (κ 72.4%). Seventy-one percent (n = 120/170) of women preferred a non-speculum sample for their next screen. CONCLUSION: HPV testing on non-speculum clinician-taken samples is a viable approach that warrants further exploration in larger studies. Overall test performance was broadly comparable with that of self-sampling.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Landy R, Hollingworth T, Waller J, et al. Non-speculum clinician-taken samples for human papillomavirus testing: a cross-sectional study in older women. Br J Gen Pract. 2022. PMID: 35667684. doi:10.3399/BJGP.2021.0708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。